您当前的位置:
首页 >
文章列表页 >
Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)
Guideline and Consensus | 更新时间:2025-12-31
    • Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)

    • China Oncology   Vol. 32, Issue 8, Pages: 747-756(2022)
    • DOI:10.19401/j.cnki.1007-3639.2022.08.010    

      CLC: R737.3
    • Received:14 July 2022

      Revised:2022-08-22

      Published:30 August 2022

    移动端阅览

  • Committee of China Anti-Cancer Association, Multidisciplinary Cancer Diagnosis and Treatment Committee of Chinese Medical Doctor Association The Society of Gynecological Cancer of China Anti-Cancer Association, Multidisciplinary Diagnosis and Treatment (MDT). Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)[J]. China Oncology, 2022, 32(8): 747-756. DOI: 10.19401/j.cnki.1007-3639.2022.08.010.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

3262

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version)
Research progress on the regulation of tumor malignancy by lactate
Expert consensus on BRCA1/2 gene testing and clinical application in Chinese breast cancer patients (2025 edition)
Chinese expert consensus on whole-process management of chemotherapy-related diarrhea (2025 edition)
Research progress and prospect of histone lactylation in digestive system tumors

Related Author

Society of Cancer Endocrinology, China Anti-Cancer Association The
Society of Cancer Multidisciplinary Diagnosis and Treatment, China Anti-Cancer Association The
Shengtao CHENG
Wanjin CHEN
Zhiling WANG
Xichun HU
Yongmei YIN
Hongxia WANG

Related Institution

The Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education, Chongqing Medical University
Committee of Breast Cancer Society, Chinese Anti-Cancer Association; Clinical Precision Medicine Professional Committee, Chinese Medical Doctor Association; Tumor Heterogeneity and Personalized Therapy Professional Committee, Chinese Anti-Cancer Association
Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530000, Guangxi Zhuang Autonomous Region
Department of Digestive Oncology, Guangxi Medical University Cancer Hospital, Nanning 530000, Guangxi Zhuang Autonomous Region
Department of Medical Oncology, The Fifth Medical Center, Chinese PLA General Hospital
0